Taxmen begin scrutiny of Unilever-GSK deal
Wednesday, December 5, 2018, 8:08 AM
Taxmen have begun to scrutinise the $3.8-billion (3.3-billion euro) Unilever-GSK transaction and could raise demand on the value of the sale of Horlicks brand to the Anglo-Dutch multinational by invoking provisions relating to indirect transfer of shares, tax experts and lawyers said on Tuesday. The deal between Unilever and GSK can attract up to 40% tax, experts said.
The message for the Horlicks maker in the Complan deal
Thursday, October 25, 2018, 8:36 AM
While health drinks such as Complan and Horlicks earn decent margins, their sales growth has slowed down. Their owners are therefore selling out even as competition is getting tougher. If the Complan deal is any indication, valuations are facing a dose of reality. In FY18, the Heinz India Pvt. Ltd brands being acquiredComplan, Nycil, Glucon-D and Sampritiearned revenues of 1,130 crore.